| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |